TEL AVIV, Jan 9 Israel-based Mobileye, which
makes technology for autonomous driving, said on Tuesday it was
expanding its business in China with two new partnerships,
paving the way for smaller Israeli competitors that could
benefit from U.S.-Sino trade tensions.
TEL AVIV Israel-based Mobileye, which makes technology for autonomous driving, said on Tuesday it was expanding its business in China with two new partnerships, paving the way for smaller Israeli competitors that could benefit from U.S.-Sino trade tensions.
TEL AVIV Israel is struggling to recruit enough workers to its technology sector, a report showed on Sunday, creating a challenge for an industry seen as the country's main potential driver of economic growth over the next decade.
TEL AVIV Mexican industrial group Mexichem is establishing an innovation hub in Israel, building on this year's acquisition of Israeli drip irrigation pioneer Netafim.
TEL AVIV Israel is unrolling a major pipeline of investments to get rid of persistent traffic jams that are hampering economic growth. To unclog the developed world's most congested roads, the government will partner with private contractors and banks, both Israeli and foreign, marking a shift in policy after a series of transport projects were criticized for delays and mismanagement.
TEL AVIV Israeli defense firm Elbit Systems reported a 4 percent rise in third-quarter net profit on Tuesday, boosted by higher sales in North America and Asia as well as its acquisition of U.S.-based Universal Avionics Systems Corp.
TEL AVIV, Nov 15 Bank Hapoalim,
Israel's largest lender, reported higher quarterly net profit
that beat estimates, but again decided not to pay a quarterly
dividend due to an ongoing U.S. tax evasion investigation.
TEL AVIV Franklin Templeton Investments entered the $67 billion Israeli retail market on Tuesday after the government allowed foreign firms to offer offshore products directly to investors.
TEL AVIV Teva Pharmaceutical Industries raised its 2018 earnings outlook, said it was seeing "a very strong launch" for its long-awaited migraine treatment Ajovy and expects to launch generic EpiPen in the fourth quarter.